Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: BigKNY3 who wrote (7504)	4/24/1999 12:30:00 AM
From: BigKNY3	Respond to of 9523

The Big Pharma Report: 4/23/99 Have a PFun Weekend! BigKNY3 ________________________________________________________ Big Pharma Scoreboard 4/23/99 - A wild roller coaster, sector rotating week for Big Pharma .....which still managed a 1.3% gain for the week. -Earnings dominated the headlines with pluses for JNJ (+9.3%) and BMY (+9.3%) and a minus for LLY (-9.8%) -Despite a positive FDA Vioxx Advisory Panel and meeting the 1 Qt EPS Consensus, MRK dropped 2.4% for the week. -After a major early week drop, PFE recovered and was unchanged for the week...except for the buy opportunities. -We have a race for the YTD leader in Big Pharma! JNJ (+21.3%YTD) actually led .....until AMGN (+24.6%YTD) came back on Friday. -Overall, Big Pharma (+1.8%YTD) is trailing the Dow (+16.4%) and the NASTie (+18.1%) -LLY (-16.5% YTD) is singing the Prozac blues in da cellar. . Price % Chg % Chg % Chg Rank . 04/23/99 Week April YTD 1999 1 Amgen 65.13 -2.5% -13.0% 24.6% 2 J&J 101.75 9.3% 8.8% 21.3% 3 Amer 65.25 4.1% 0.0% 15.7% 4 Abbott 52.94 7.9% 13.1% 8.0% 5 Pharma 59.81 1.7% -4.1% 5.6% 6 Merck 75.75 -2.4% -5.5% 2.7% 7 Pfizer 127.00 0.0% -8.4% 1.6% 8 Bristol 67.06 9.3% 4.6% 0.2% 9 Scher 53.69 2.3% -5.8% -2.8% 10 Smith 67.38 1.0% -2.8% -3.1% 11 Warner 67.88 0.7% 2.5% -9.7% 12 Glaxo 60.44 -0.5% -9.7% -13.0% 13 Lilly 74.25 -9.8% -12.6% -16.5% Big Pharma 72.18 1.3% -3.3% 1.8% Dow 10,690 1.9% 9.2% 16.4% S&P 500 1,357 2.9% 5.5% 10.4% NASDAQ 2,590 4.4% 5.2% 18.1% News/chart/quote links to Big Pharma and ED stocks: Yahoo! PFE News biz.yahoo.com Five Day Chart of PFE versus the Dow quicken.com A great PFE Stat Website dailystocks.com Labpuppy.com Drug Stock Commentary (scroll down after opening) labpuppy.com A New Investment Website Worth A Try bridge.com Big Pharma Yahoo Link quote.yahoo.com Motley Fool Link quote.fool.com ED Stocks Yahoo Link quote.yahoo.com Motley Fool Link quote.fool.com PFE Split Information Originally posted in January everything below was announced on 4/22/99 by PFE: -On the April 22, 1999 Annual Meeting, PFE shareholders will officially approved an increase in authorized outstanding shares that will permit a 3-1 split. -Following the Annual Meeting, the PFE Board is scheduled to meet and announce the 3-1 split and its effective date....Expected to be following the June 30, 1999 close. The 1999 Pharma Portfolio Challenge: Motley Fool /SI Challenge Highlights -MERCKGAL (+15.6%) moved up to #1 with her play on AHP (Portfolio: AHP 99%, MRK 1%). -McMenus(+9.6) moved up to second place (Portfolio: 40% PFE, 25% AMGN/MRK, 10%:JNJ) -Ron Flanagan (+9.5% ) moved down to #3 (Portfolio: 33% PFE/MRK/AMGN, 1% Cash). -GaryD711 (9.1%) jumped 14 places to 4th place (Portfolio: 40% ABT, 35% PFE, 25% JNJ) -The five 100% PFErs (+1.6%) dropped to 31st place (Portfolio: 100% PFE) -Supporting the principles behind the Peabody Model: PEABODY PURCHASE (+4.0%) is beating the PFE DRIP (+1.0%). -The PEABODY PEAK SHORT (+7.3%) remains strong. This portfolio shorts PFE at confirmed Peabody Peaks (in the amount of $833 representing 1/12th of the original cah investment of $10,000). (Portfolio: 63% cash, 17.50 shares short PFE) purchased at the 3 1999 Peabody Peaks; 134.63, 144.50, and 150.13) -SHORT PFE (-1.6%) dropped to 49th place (Portfolio: 100% short PFE) Click here for a breakdown of the holdings of the 64 Challenge portfolios www3.techstocks.com